Skip to main content

Animations

MJFF Publications

1321 - 1330 of 8826 Results
Title
Year
  • Year
  • 2021
  • 2019
  • 2019
  • 2018
  • 2022
  • 2019
  • 2025
  • 2018
  • 2024
  • 2021
  • Summary Details
    OPEN
    Title: Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
    Journal Name: Frontiers in Cell and Developmental Biology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fcell.2020.615461
    Citation Count: 124
  • Summary Details
    OPEN
    Title: Nucleic Acid–Based Therapeutics for Parkinson's Disease
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-019-00714-7
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12874
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches
    Journal Name: Bioconjugate Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.8b00548
    Citation Count: 53
  • Summary Details
    OPEN
    Title: The complex role of inflammation and gliotransmitters in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105940
    Citation Count: 38
  • Therapeutic approaches to cholinergic deficiency in Lewy body diseases
    2019
    Summary Details
    RESTRICTED
    Title: Therapeutic approaches to cholinergic deficiency in Lewy body diseases
    Journal Name: Expert Review of Neurotherapeutics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14737175.2020.1676152
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Clinical Chronobiology: Circadian Rhythms in Health and Disease
    Journal Name: Seminars in Neurology
    Publisher: Georg Thieme Verlag KG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1055/a-2538-3259
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Targeting the proteostasis network in Huntington’s disease
    Journal Name: Ageing Research Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.arr.2018.11.006
    Citation Count: 78
  • Summary Details
    OPEN
    Title: A framework for translating tauopathy therapeutics: Drug discovery to clinical trials
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14250
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Adapting the proteostasis capacity to sustain brain healthspan
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cell.2021.02.007
    Citation Count: 108
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.